Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors

Bioorg Med Chem. 2010 Nov 1;18(21):7580-5. doi: 10.1016/j.bmc.2010.08.047. Epub 2010 Oct 1.

Abstract

5-Lipoxygenase (5-LOX) is important enzyme in the biosynthesis of leukotrienes, and is a potential target in the treatment of asthma and allergy. We designed and synthesized a series of benzoxazoles and benzothiazoles as 5-LOX inhibitors. Fourteen compounds prepared showed the inhibition of LTC4 formation with IC(50) value of 0.12-23.88 μM. Also two compounds 2d and 2g showed improved airway hypersensitiveness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / toxicity
  • Animals
  • Arachidonate 5-Lipoxygenase / chemistry*
  • Arachidonate 5-Lipoxygenase / metabolism
  • Asthma / chemically induced
  • Asthma / drug therapy
  • Asthma / pathology
  • Benzoxazoles / chemical synthesis
  • Benzoxazoles / chemistry*
  • Benzoxazoles / therapeutic use
  • Lipoxygenase Inhibitors / chemical synthesis*
  • Lipoxygenase Inhibitors / chemistry
  • Lipoxygenase Inhibitors / therapeutic use
  • Mice
  • Structure-Activity Relationship

Substances

  • Allergens
  • Benzoxazoles
  • Lipoxygenase Inhibitors
  • Arachidonate 5-Lipoxygenase